Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Biochimica et Biophysica Acta

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10899442
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteolytic Processing of the Alzheimer’s Disease Amyloid Precursor Protein within Its Cytoplasmic Domain by Caspase-like Proteases*

  1999cited by this paper
• The presence of isoaspartic acid in beta-amyloid plaques indicates plaque age.

  1999cited by this paper
• Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease.

  1999cited by this paper
• Accumulation of murine amyloidβ42 in a gene‐dosage‐dependent manner in PS1 ‘knock‐in’ mice

  1999cited by this paper
• Lipoprotein‐free amyloidogenic peptides in plasma are elevated in patients with sporadic Alzheimer's disease and Down's syndrome

  1999cited by this paper
• Cerebrospinal fluid Aβ42 is increased early in sporadic Alzheimer's disease and declines with disease progression

  1999cited by this paper
• γ-Secretase, Evidence for Multiple Proteolytic Activities and Influence of Membrane Positioning of Substrate on Generation of Amyloid β Peptides of Varying Length*

  1999cited by this paper
• High levels of circulating Abeta42 are sequestered by plasma proteins in Alzheimer's disease.

  1999cited by this paper
• Unusual phenotypic alteration of beta amyloid precursor protein (betaAPP) maturation by a new Val-715 --> Met betaAPP-770 mutation responsible for probable early-onset Alzheimer's disease.

  1999cited by this paper
• Flemish and Dutch mutations in amyloid beta precursor protein have different effects on amyloid beta secretion.

  1998cited by this paper
• Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease.

  1998cited by this paper
• Neurodegenerative Alzheimer-like pathology in PDAPP 717V-->F transgenic mice.

  1998cited by this paper
• Detection of single amyloid β-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy

  1998cited by this paper
• Mutant human presenilin 1 protects presenilin 1 null mouse against embryonic lethality and elevates Abeta1-42/43 expression.

  1998cited by this paper
• GM1 ganglioside-bound amyloid beta-protein in Alzheimer's disease brain.

  1998cited by this paper
• Increased Aβ42(43) from cell lines expressing presenilin 1 mutations

  1998cited by this paper
• N‐terminal Heterogeneity of Parenchymal and Cerebrovascular Aβ Deposits

  1998cited by this paper
• Mutant Presenilin 2 Transgenic Mouse: Effect on an Age‐Dependent Increase of Amyloid β‐Protein 42 in the Brain

  1998cited by this paper
• Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red.

  1998cited by this paper
• The role of A beta 42 in Alzheimer's disease.

  1998cited by this paper
• The presence of amyloid beta-protein in the detergent-insoluble membrane compartment of human neuroblastoma cells.

  1998cited by this paper
• The HHQK Domain of β-Amyloid Provides a Structural Basis for the Immunopathology of Alzheimer’s Disease*

  1998cited by this paper
• Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

  1998cited by this paper
• Increased Production of Amyloid Precursor Protein Provides a Substrate for Caspase-3 in Dying Motoneurons

  1998cited by this paper
• Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

  1998cited by this paper
• Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity.

  1998cited by this paper
• Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor.

  1998cited by this paper
• A detergent-insoluble membrane compartment contains A beta in vivo.

  1998cited by this paper
• A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1

  1998cited by this paper
• Abeta1-40 but not Abeta1-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimer's disease.

  1997cited by this paper
• Distortion of allelic expression of apolipoprotein E in Alzheimer's disease.

  1997cited by this paper
• Isolation, chemical characterization, and quantitation of A beta 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits.

  1997cited by this paper
• Alzheimer's Aβ(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells

  1997cited by this paper
• Amyloid beta-protein (A beta) associated with lipid molecules: immunoreactivity distinct from that of soluble A beta.

  1997cited by this paper
• Charge-based binding of complement component C1q to the Alzheimer amyloid beta-peptide.

  1997cited by this paper
• Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides

  1997cited by this paper
• Intracellular Generation and Accumulation of Amyloid β-Peptide Terminating at Amino Acid 42*

  1997cited by this paper
• Aspartate residue 7 in amyloid β-protein is critical for classical complement pathway activation: Implications for Alzheimer's disease pathogenesis

  1997cited by this paper
• Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice

  1997cited by this paper
• A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of A beta 42(43).

  1997cited by this paper
• Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol microdomains.

  1997cited by this paper
• Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins.

  1997cited by this paper
• Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.

  1997cited by this paper
• Heterogeneity of water‐soluble amyloid β‐peptide in Alzheimer's disease and Down's syndrome brains

  1997cited by this paper
• Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein.

  1997cited by this paper
• The interaction between Alzheimer amyloid β(1–40) peptide and ganglioside GM1‐containing membranes

  1997cited by this paper
• The Pathogenesis of Senile Plaques

  1997cited by this paper
• The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue.

  1997cited by this paper
• No association between the intronic presenilin-1 polymorphism and Alzheimer's disease in clinic and population-based samples.

  1997cited by this paper
• Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

  1997cited by this paper
• Acceleration of Amyloid Fibril Formation by Specific Binding of Aβ-(1–40) Peptide to Ganglioside-containing Membrane Vesicles*

  1997cited by this paper
• Alzheimer's soluble amyloid beta is a normal component of human urine.

  1997cited by this paper
• Enhanced Production and Oligomerization of the 42-residue Amyloid β-Protein by Chinese Hamster Ovary Cells Stably Expressing Mutant Presenilins*

  1997cited by this paper
• The beta APP717 Alzheimer mutation increases the percentage of plasma amyloid-beta protein ending at A beta 42(43)

  1997cited by this paper
• Characterization of New Polyclonal Antibodies Specific for 40 and 42 Amino Acid-Long Amyloid β Peptides: Their Use to Examine the Cell Biology of Presenilins and the Immunohistochemistry of Sporadic Alzheimer’s Disease and Cerebral Amyloid Angiopathy Cases

  1997cited by this paper
• Different effects of Alzheimer-associated mutations of presenilin 1 on its processing.

  1997cited by this paper
• Improved electrophoretic separation and immunoblotting of beta‐amyloid (Aβ) peptides 1–40, 1–42, and 1–43

  1997cited by this paper
• Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease.

  1997cited by this paper
• Comparison of Neurodegenerative Pathology in Transgenic Mice Overexpressing V717F β-Amyloid Precursor Protein and Alzheimer’s Disease

  1996cited by this paper
• Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo.

  1996cited by this paper
• Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains.

  1996cited by this paper
• Mechanisms of neuronal degeneration in Alzheimer's disease.

  1996cited by this paper
• Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1

  1996cited by this paper
• Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.

  1996cited by this paper
• The profile of soluble amyloid beta protein in cultured cell media. Detection and quantification of amyloid beta protein and variants by immunoprecipitation-mass spectrometry.

  1996cited by this paper
• Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

  1996cited by this paper
• Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

  1995cited by this paper
• Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43).

  1995cited by this paper
• GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer's disease.

  1995cited by this paper
• Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques.

  1995cited by this paper
• Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E.

  1995cited by this paper
• Chemical characterization of A beta 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease.

  1994cited by this paper
• Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation.

  1994cited by this paper
• Neuroimmune Mechanisms in Alzheimer Disease Pathogenesis

  1994cited by this paper
• An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

  1994cited by this paper
• Apolipoprotein E Affects the Rate of Alzheimer Disease Expression: (β-Amyloid Burden Is a Secondary Consequence Dependent on APOE Genotype and Duration of Disease

  1994cited by this paper
• Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor.

  1994cited by this paper
• Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

  1994cited by this paper
• Increased β‐amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutation

  1994cited by this paper
• Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta-amyloid or A4 peptides.

  1993cited by this paper
• beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease.

  1993cited by this paper
• Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells.

  1993cited by this paper
• The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease.

  1993cited by this paper
• Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide.

  1993cited by this paper
• Release of excess amyloid beta protein from a mutant amyloid beta protein precursor.

  1993cited by this paper
• The C-terminus of the beta protein is critical in amyloidogenesis.

  1993cited by this paper
• Is the "preamyloid" of diffuse plaques in Alzheimer's disease really nonfibrillar?

  1993cited by this paper
• Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease.

  1993cited by this paper
• Amyloid beta-peptide is produced by cultured cells during normal metabolism.

  1992cited by this paper
• Complement activation by beta-amyloid in Alzheimer disease.

  1992cited by this paper
• Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids

  1992cited by this paper
• Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β–amyloid precursor protein gene

  1992cited by this paper
• Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production.

  1992cited by this paper
• Production of the Alzheimer amyloid beta protein by normal proteolytic processing.

  1992cited by this paper
• Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.

  1990cited by this paper
• Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease.

  1987cited by this paper
• Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.

  1987cited by this paper
• Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides.

  1987cited by this paper
• Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus.

  1987cited by this paper
• The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

  1987cited by this paper

• The Icelandic Mutation in the Murine APP Gene, mAPPA673T, on Amyloid-β Plaque Burden in the 5×FAD Alzheimer Model.

  2026cites this paper
• Unraveling the mystery of citrate transporters in Alzheimer's disease: An updated review.

  2025cites this paper
• Antioxidants Trolox and Methazolamide Protect Microvascular Endothelial Cells from Oxidative Damage Induced by Sporadic and Familial Forms of Oligomeric Amyloid-β

  2025cites this paper
• Systematic review and meta‐analysis of bulk RNAseq studies in human Alzheimer's disease brain tissue

  2025cites this paper
• Probing locus coeruleus functional network in healthy aging and its association with Alzheimer’s disease biomarkers using pupillometry

  2025cites this paper
• Voxel-Based Morphometric Analysis of the Mini-Mental State Examination and the Mini-Mental State Examination-2 in Patients With Mild Cognitive Impairment and Alzheimer’s Disease in Korea

  2025cites this paper
• The Icelandic mutation APPA673T on amyloid-β plaque burden in the 5xFAD Alzheimer model

  2025cites this paper
• Linking higher amyloid beta 1‐38 (Aβ(1‐38)) levels to reduced Alzheimer's disease progression risk

  2025cites this paper
• Nanopore sensing of protein and peptide conformation for point-of-care applications

  2025cites this paper
• Cerebrospinal Fluid p‑Tau181/Amyloid Beta 42 Ratio Identifies Lymphatic-Venous Anastomosis Patients Who Respond to and Benefit from the Surgery for Relief of Cognitive Impairment with a Diagnostic Accuracy of 0.744

  2025cites this paper
• Psychoactive substances: novel molecular insights and therapeutic potential for Alzheimer's disease

  2025cites this paper
• Design, Ssynthesis, and biological evaluation of β-secretase inhibitors: An integrated study of molecular docking, dynamics, pharmacokinetics, quantum chemistry, and in-vitro analysis for Alzheimer's disease.

  2025cites this paper
• Protective effects of Cuscuta chinensis Lam. extract against learning and memory dysfunction induced by streptozotocin and amyloid β25-35 in vivo model

  2025cites this paper
• Brazilin-7-2-butenoate inhibits amyloid β-protein aggregation, alleviates cytotoxicity, and protects Caenorhabditis elegans.

  2024cites this paper
• Investigating the combined effect of copper, zinc, and iron ions on truncated and full-length Aβ peptides: insights from molecular dynamics simulation

  2024cites this paper
• Label-free detection of Aβ-42: a liquid crystal droplet approach for Alzheimer's disease diagnosis

  2024cites this paper
• Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis

  2024cites this paper
• Prominent tauopathy and intracellular β-amyloid accumulation triggered by genetic deletion of cathepsin D: implications for Alzheimer disease pathogenesis

  2024influential citation
• Glymphatic system dysfunction in neurodegenerative diseases

  2024cites this paper
• Unlocking the Molecular Variations of a Micron-Scale Amyloid Plaque in an Early Stage Alzheimer's Disease by a Cellular-Resolution Mass Spectrometry Imaging Platform.

  2024cites this paper
• Systematic review and meta-analysis of bulk RNAseq studies in human Alzheimer’s disease brain tissue

  2024cites this paper
• Therapeutic potential and microRNA regulating properties of phytochemicals in Alzheimer’s disease

  2024cites this paper
• The Association of Selected GWAS Reported AD Risk Loci with CSF Biomarker Levels and Cognitive Decline in Slovenian Patients

  2023cites this paper
• Contribution of A-to-I RNA editing, M6A RNA Methylation, and Alternative Splicing to physiological brain aging and neurodegenerative diseases.

  2023cites this paper
• The heritability of blood‐based biomarkers related to risk of Alzheimer's disease in a population‐based sample of early old‐age men

  2023cites this paper
• Neuroprotective effects of coenzyme Q10 on neurological diseases: a review article

  2023cites this paper
• Focused ultrasound mitigates pathology and improves spatial memory in Alzheimer's mice and patients

  2023cites this paper
• Subcellular proteomics insights into Alzheimer's disease development

  2023cites this paper
• Prominent tauopathy and intracellular β-amyloid accumulation triggered by genetic deletion of cathepsin D: Implications for Alzheimer disease pathogenesis

  2023cites this paper
• Multi-Targeting Intranasal Nanoformulation as a Therapeutic for Alzheimer’s Disease

  2023cites this paper
• DNAzyme-driven bipedal DNA walker triggered to hybridize silver nanoparticle probes for electrochemical detection of amyloid-β oligomer.

  2023cites this paper
• Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer’s disease: Current trends and future perspectives

  2022cites this paper
• Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer’s disease related proteins

  2022cites this paper
• Prediction of Cognitive Progression in Individuals with Mild Cognitive Impairment Using Radiomics as an Improvement of the ATN System: A Five-Year Follow-Up Study

  2022cites this paper
• The genetic and environmental etiology of blood-based biomarkers related to risk of Alzheimer’s Disease in a population-based sample of early old-age men

  2022cites this paper
• Selenium-derivative compounds: a review of new perspectives in the treatment of Alzheimer's disease.

  2022cites this paper
• Alzheimer’s disease – the journey of a healthy brain into organ failure

  2022cites this paper
• A structural analysis of amyloid polymorphism in disease: clues for selective vulnerability?

  2021cites this paper
• Postmortem Neocortical 3H-PiB Binding and Levels of Unmodified and Pyroglutamate Aβ in Down Syndrome and Sporadic Alzheimer’s Disease

  2021cites this paper
• Development of liquid crystal biosensor for the detection of amyloid beta-42 levels associated with Alzheimer's disease.

  2021cites this paper
• NLRP3 Inflammasome: A Starring Role in Amyloid-β- and Tau-Driven Pathological Events in Alzheimer’s Disease

  2021cites this paper
• Silk Fibroin As an Immobilization Matrix for Sensing Applications.

  2021cites this paper
• Genetic Variability in Molecular Pathways Implicated in Alzheimer's Disease: A Comprehensive Review

  2021cites this paper
• Amyloid-β1-40 differentially stimulates proliferation, activation of oxidative stress and inflammatory responses in male and female hippocampal astrocyte cultures.

  2021cites this paper
• Prenatal exposure to bisphenol A alters the transcriptome-interactome profiles of genes associated with Alzheimer’s disease in the offspring hippocampus

  2020cites this paper
• Aß40 displays amyloidogenic properties in the non-transgenic mouse brain but does not exacerbate Aß42 toxicity in Drosophila

  2020influential citation
• Cathepsin D regulates cerebral Aβ42/40 ratios via differential degradation of Aβ42 and Aβ40

  2020cites this paper
• An electrochemical aptasensor for amyloid-β oligomer based on double-stranded DNA as “conductive spring”

  2020cites this paper
• The Importance of Understanding Amylin Signaling Mechanisms for Therapeutic Development in the Treatment of Alzheimer's Disease.

  2020cites this paper
• Transition metal-coordinated graphitic carbon nitride dots as a sensitive and facile fluorescent probe for β-amyloid peptide detection.

  2019cites this paper
• Mitigating Alzheimer's Disease by Natural Polyphenols : A Review.

  2019cites this paper
• Bidirectional relationship between sleep and Alzheimer’s disease: role of amyloid, tau, and other factors

  2019cites this paper
• Neurotheranostics as personalized medicines.

  2019cites this paper
• Full genome analysis of microglial activation : ramifications of TREM2

  2019cites this paper
• Development of Gleevec Analogues for Reducing Production of β-Amyloid Peptides through Shifting β-Cleavage of Amyloid Precursor Proteins.

  2019cites this paper
• Sleep and Attention in Alzheimer’s Disease

  2019cites this paper
• Oxidative Stress, DNA Damage and Repair Pathways in Patients with Type 2 Diabetes Mellitus

  2019cites this paper
• β-Sheet Breaker Peptide-HPYD for the Treatment of Alzheimer's Disease: Primary Studies on Behavioral Test and Transcriptional Profiling

  2018cites this paper
• Insulin Resistance as a Therapeutic Target in the Treatment of Alzheimer's Disease: A State-of-the-Art Review

  2018cites this paper
• Amyloid-β Plaques in Clinical Alzheimer’s Disease Brain Incorporate Stable Isotope Tracer In Vivo and Exhibit Nanoscale Heterogeneity

  2018cites this paper
• Light-Up Nonthiolated Aptasensor for Low-Mass, Soluble Amyloid-β40 Oligomers at High Salt Concentrations.

  2018cites this paper
• Design of novel amyloid β aggregation inhibitors using QSAR, pharmacophore modeling, molecular docking and ADME prediction

  2018cites this paper
• Biosensors for Alzheimer's disease biomarker detection: A review.

  2018cites this paper
• Highly sensitive/selective 3D nanostructured immunoparticle-based interface on a multichannel sensor array for detecting amyloid-beta in Alzheimer's disease

  2018cites this paper
• Effects of amyloid pl-42 investigated by in vivo single-unit electrophysiology: Ionotropic glutamate receptors and neuroprotection Ph.D. Thesis

  2018cites this paper
• Paper-based electrochemiluminescence sensor for highly sensitive detection of amyloid-β oligomerization: Toward potential diagnosis of Alzheimer's disease

  2018cites this paper
• The Emerging Relationship Between Interstitial Fluid-Cerebrospinal Fluid Exchange, Amyloid-β, and Sleep.

  2018cites this paper
• Short Aβ peptides attenuate Aβ42 toxicity in vivo

  2018cites this paper
• ZnO nanoflower based sensitive nano-biosensor for amyloid detection.

  2017cites this paper
• A sensitive and selective electrochemical biosensor for the determination of beta-amyloid oligomer by inhibiting the peptide-triggered in situ assembly of silver nanoparticles

  2017cites this paper
• In Vitro Quantified Determination of β-Amyloid 42 Peptides, a Biomarker of Neuro-Degenerative Disorders, in PBS and Human Serum Using a Simple, Cost-Effective Thin Gold Film Biosensor

  2017cites this paper
• A Critical Review on the Association between eIF2 and Neurodegenerative Diseases

  2017cites this paper
• Alzheimer’s disease in the zebrafish: where can we take it?

  2017cites this paper
• Beneficial effects of a pyrroloquinolinequinone-containing dietary formulation on motor deficiency, cognitive decline and mitochondrial dysfunction in a mouse model of Alzheimer’s disease

  2017cites this paper
• Impact of Mutations at C-Terminus on Structures and Dynamics of Aβ40 and Aβ42: A Molecular Simulation Study.

  2017cites this paper
• Combined determination of copper ions and β-amyloid peptide by a single ratiometric electrochemical biosensor.

  2017cites this paper
• Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer’s disease

  2017cites this paper
• Visual and fluorescent assays for selective detection of beta-amyloid oligomers based on the inner filter effect of gold nanoparticles on the fluorescence of CdTe quantum dots.

  2016cites this paper
• Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors.

  2016cites this paper
• Apolipoprotein E4: A Risk Factor for Successful Cognitive Aging

  2016cites this paper
• CSF biomarkers in neurodegenerative and vascular dementias.

  2016cites this paper
• Transcriptomic gene-network analysis of exposure to silver nanoparticle reveals potentially neurodegenerative progression in mouse brain neural cells.

  2016cites this paper
• Amyloid Beta Influences Vascular Smooth Muscle Contractility and Mechanoadaptation.

  2016cites this paper
• Non-invasive screening for early Alzheimer’s disease diagnosis by a sensitively immunomagnetic biosensor

  2016cites this paper
• Perilla frutescens var. japonica and rosmarinic acid improve amyloid-β25-35 induced impairment of cognition and memory function

  2016cites this paper
• Diosmin reduces cerebral Aβ levels, tau hyperphosphorylation, neuroinflammation, and cognitive impairment in the 3xTg-AD mice.

  2016cites this paper
• Hologram QSAR Models of a Series of 6-Arylquinazolin-4-Amine Inhibitors of a New Alzheimer’s Disease Target: Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase-1A Enzyme

  2015cites this paper
• Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer’s disease

  2015cites this paper
• Short-term effects of extremely low frequency electromagnetic fields exposure on Alzheimer's disease in rats

  2015cites this paper
• The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer's disease mouse model.

  2015cites this paper
• Cholestenoic acid, an endogenous cholesterol metabolite, is a potent γ-secretase modulator

  2015cites this paper
• Alzheimer's disease

  2015cites this paper
• Gelsolin bound β-amyloid peptides(1-40/1-42): electrochemical evaluation of levels of soluble peptide associated with Alzheimer's disease.

  2015cites this paper
• A method for evaluating the level of soluble β-amyloid(1-40/1-42) in Alzheimer's disease based on the binding of gelsolin to β-amyloid peptides.

  2014cites this paper
• Impact of sequence on the molecular assembly of short amyloid peptides

  2014cites this paper
• The Murine Version of BAN2401 (mAb158) Selectively Reduces Amyloid-β Protofibrils in Brain and Cerebrospinal Fluid of tg-ArcSwe Mice

  2014cites this paper
• Complex Relationships between Substrate Sequence and Sensitivity to Alterations in γ-Secretase Processivity Induced by γ-Secretase Modulators

  2014cites this paper
• Brain Intraventricular Injection of Amyloid-β in Zebrafish Embryo Impairs Cognition and Increases Tau Phosphorylation, Effects Reversed by Lithium

  2014cites this paper
• Metallothionein‐III increases ADAM10 activity in association with furin, PC7, and PKCα during non‐amyloidogenic processing

  2014cites this paper
• Independent Relationship between Amyloid Precursor Protein (APP) Dimerization and γ-Secretase Processivity

  2014cites this paper